Skip to main content

Animations

MJFF Publications

3081 - 3090 of 8571 Results
Title
Year
  • Year
  • 2024
  • 2014
  • 2025
  • 2019
  • 2019
  • 2018
  • 2025
  • 2016
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01144-2
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: What matters to people with Parkinson’s disease living in Australia?
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097
    Best OA location URL:
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01026-8
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.006
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz260
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.13028
    Best OA location URL:
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Fears and uncertainties of people with Parkinson's disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251328565
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013
    Best OA location URL:
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease
    Journal Name: Journal of Biopharmaceutical Statistics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/10543406.2023.2170400
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28779
    Citation Count: 135
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.